Filter
807
Text search:
DR
Congo
Featured
Recommendations
72
New Publications
307
Language
Document type
No document type
546
Studies & Reports
128
Guidelines
46
Manuals
27
Strategic & Response Plan
24
Situation Updates
19
Infographics
6
Fact sheets
6
Training Material
4
Resource Platforms
1
Countries / Regions
Congo, Democratic Republic of
207
Africa
37
Sierra Leone
30
Liberia
26
Uganda
24
Global
24
Guinea
19
Rwanda
18
Nigeria
17
Zambia
16
Senegal
15
West and Central Africa
15
Burkina Faso
13
East and Southern Africa
13
Central African Republic
12
South Africa
11
Kenya
10
Tanzania
10
Cameroon
9
Mozambique
9
Ghana
8
South Sudan
8
Malawi
8
Benin
8
Afghanistan
7
Mali
6
Ethiopia
6
Haiti
6
Western and Central Europe
6
Côte d’Ivoire / Ivory Coast
5
Zimbabwe
5
Latin America and the Carribbean
5
Niger
4
India
4
Pakistan
4
Syria
4
Bangladesh
4
Myanmar / Burma
4
Guinea-Bissau
3
Somalia
3
Indonesia
3
Yemen
3
Middle East and North Africa
3
Venezuela
3
Congo-Brazzaville
3
Togo
2
Philippines
2
Germany
2
Sudan
2
Namibia
2
Eswatini/ Swaziland
2
Angola
2
Madagascar
2
Lesotho
2
South–East Asia Region
2
Southern Africa
2
Morocco
1
Iraq
1
Cambodia
1
China
1
Papua New Guinea
1
North Macedonia
1
Ukraine
1
Colombia
1
Botswana
1
Mexico
1
Paraguay
1
Eastern Europe
1
Palestine
1
North America
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
322
Clinical Guidelines
66
Public Health
41
Women & Child Health
37
Key Resources
20
Capacity Building
12
Pharmacy & Technologies
10
Annual Report MEDBOX
1
Toolboxes
Ebola
118
Rapid Response
56
COVID-19
48
TB
45
HIV
39
Mental Health
37
NTDs
34
Conflict
24
Planetary Health
18
Disability
15
Global Health Education
14
Refugee
13
Polio
9
Natural Hazards
9
Health Financing Toolbox
9
Cholera
8
Pharmacy
8
Caregiver
7
AMR
6
Specific Hazards
5
NCDs
3
Zika
2
Social Ethics
2
Typhoon
1
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
DG Echo Funding Guidelines
What are the local beliefs and practices around illnesses and death, the transmission of disease and spirituality, which affect decision-making (around health-seeking behaviour, caring for relatives and nature of burials) and can inform effective behaviour change interventions for preventing Ebola i
...
This guide is an introduction on how to integrate logistics management information systems (LMIS) with geographic information systems (GIS). It covers the value of integrating these two systems, the steps in assessing if it is currently viable to link the systems, how to set the linkage, the process
...
This pan-African report describes and analyses the cultural, social, physical and other societal barriers preventing children with disabilities in Africa from realising their full human potential. It also describes the opportunities, initiatives and good practices that exist, that indicate the progr
...
This helpdesk report seeks to establish what lessons have been learnt from the current and previous Ebola outbreaks. It recommends good practice and makes suggestions based on the evidence for good practice and preparedness to reduce transmission and prevent further risk and exposure in affected cou
...
Results and Lessons Learned from CapacityPlus 2009-2015
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
WHO/HTM/TB/2007.384a
“TB is too often a death sentence for people with AIDS.
It does not have to be this way.”
-Nelson Mandela, International conference on HIV /AIDS, Bangkok, Thailand, July 2004
Key populations brief
Accessed 2017
Informe sobre poblaciones clave
